Nuveen Asset Management, LLC Day One Biopharmaceuticals, Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 141,298 shares of DAWN stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
141,298
Previous 163,698
13.68%
Holding current value
$1.17 Million
Previous $2.28 Million
21.49%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DAWN
# of Institutions
176Shares Held
77.8MCall Options Held
139KPut Options Held
253K-
Atlas Venture Life Science Advisors, LLC6.43MShares$53 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$48.3 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$47.5 Million1.18% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$40.2 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$37.4 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $606M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...